Post job

Rare Genomics Institute's revenue is $17.0 million.

What is Rare Genomics Institute's revenue?

Rare Genomics Institute's annual revenue is $17.0M. Zippia's data science team found the following key financial metrics about Rare Genomics Institute after extensive research and analysis.
  • Rare Genomics Institute has 175 employees, and the revenue per employee ratio is $97,143.
  • Rare Genomics Institute peak revenue was $17.0M in 2024.

On this page

Peak revenue
$17.0M (2025)
Company peak revenue
Revenue / employee
$97,143
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$17.0M (2025)
Company peak revenue
Revenue / employee
$97,143
Company revenue / employee

Rare Genomics Institute competitors

Rare Genomics Institute's top competitor, Philips Healthcare, earned an annual revenue of $6.8B.

Rare Genomics Institute's smallest competitor is prIME Oncology with revenue of $1.2M last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
Cardiac Management Systems Inc-$14.0M5-
Philips Healthcare-$6.8B24,000-
NICHQ - National Institute for Children's Health Quality-$10.0M30-
LexaMed-$11.0M41-
ECG Management Consultants-$300.0M50-
Healthcare IT Leaders-$33.5M200-
Sequoia Consulting Group, Llc-$1.3M20-
HFS Consultants-$6.8M100-
Verispan LLC-$230.0M750-
HSM Consulting--76-

Rare Genomics Institute revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Rare Genomics Institute, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Rare Genomics Institute. The employee data is based on information from people who have self-reported their past or current employments at Rare Genomics Institute. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Rare Genomics Institute. The data presented on this page does not represent the view of Rare Genomics Institute and its employees or that of Zippia.

Rare Genomics Institute may also be known as or be related to Rare Genomics Institute.